UCL Cancer Institute


Welcome to the UCL Cancer Institute 

The UCL Cancer Institute is the hub for cancer research at University College London, one of the World's leading universities. The Institute draws together over 300 talented scientists who are working together to translate research discoveries into developing better, more effective treatments to improve outcomes for cancer patients. If you are thinking about taught postgraduate study, applications to our flagship MSc Cancer programme are now open for the academic year 2017/18. 


New research sheds light on role of HPV in head and neck cancers

Human Papillomavirus (HPV) drives a greater number of head and neck cancers than previously thought, finds new research from UCL and the University of Southampton. The findings, published in the Journal of Clinical Oncology, offer valuable insight into the role of HPV in tumour development and explore the possibility of a viable treatment option for specific cancer patients.

Published: Oct 6, 2016 5:15:24 PM

UCL spin-out Achilles Therapeutics to develop immunotherapies for cancer

A new spin-out company, Achilles Therapeutics, has been launched to develop immunotherapies for cancer, based on the work of scientists from UCL and its associated hospitals. The new company will bring together world-class research from UCL and the Francis Crick Institute, funded by Cancer Research UK and the National Institute for Health Research. 

Published: Oct 6, 2016 8:36:56 AM

UCL receives largest share of NHS research funding

UCL’s three biomedical research centres (BRCs) have won more than £167 million in funding from the National Institute for Health Research (NIHR) to further world-leading biomedical research conducted with partner hospitals. UCL has received more funding than any other UK university, followed by King's College London and Oxford University, which received £133m and £127m respectively. 

Published: Sep 27, 2016 10:14:46 AM

Study reveals how ionising radiation damages DNA and causes cancer

For the first time, a team including UCL researchers has identified in human cancers two characteristic patterns of DNA damage caused by ionising radiation. These fingerprint patterns may now enable doctors to identify which tumours have been caused by radiation, and investigate if they should be treated differently. 

Published: Sep 12, 2016 5:09:44 PM

Cancer Research UK-UCL Centre

Cancer Research UK-UCL Centre

The Cancer Research UK-UCL Centre is a network and partnership between Cancer Research UK, UCL and UCL's associated Hospital Trusts. The Centre's mission is to facilitate collaboration to advance world-class translational cancer research.

Study with us

Study with us

Our education programmes reflect the depth and breadth of research expertise within the UCL Cancer Institute. Join our community of research scientists and academic clinicians through our postgraduate taught MSc Cancer or PhD studies.

Clinical Trials

Clinical Trials

The Cancer Research UK and UCL Cancer Trials Centre is one of the largest cancer trials centres in the UK. The CTC conducts multi-centre national and international phase III trials, feasibility studies and early phase I and II studies.

Our Research

Our Research

UCL is a world leader in interdisciplinary research. The UCL Cancer Institute is uniquely placed to leverage this multidisciplinary approach to advance discoveries in basic, translational and clinical cancer research.


UCL Infection, Immunology and Inflammation (III) Symposium 2016

Organised by the UCL Personalised Medicine Domain, in partnership with UCL Partners the symposium will bring together around 250 group leaders and post-doctoral researchers from across UCL and Queen Mary University of London. 

Starts: Nov 8, 2016 9:00:00 AM

Support our work

UCL philanthropy campaign research and destroy

Find out how you can help us to continue research that will lead to breakthroughs in cancer therapies and benefit the lives of cancer patients.

Taking action for equality

Athena Swan silver logo

Connect with us